Ryvu Therapeutics obtains Poland nod for Phase I/II cancer study
The new study will evaluate RVU120’s safety, tolerability, PK, PD and preliminary anti-tumour activity.
Poland
Latest in
Poland
AzurRx BioPharma adds two additional clinical trial sites in Poland
AzurRx BioPharma has added two additional clinical trial sites in Poland to reduce any potential patient enrolment delays during the…
Cyxone screens first patient in Phase II Covid-19 trial
Cyxone has announced the screening of the first participant in the Phase II clinical trial to evaluate Rabeximod for treating…
Cyxone to begin Phase II trial of oral Covid-19 drug
Cyxone is set to initiate a Phase II clinical trial with Rabeximod in moderate Covid-19 patients after it received approval…
WPD and CNS partner for paediatric brain cancer trial
WPD Pharmaceuticals and CNS Pharmaceuticals are set to initiate a Phase I clinical trial for Berubicin, an anthracycline, in paediatric…
Moleculin augments two anti-cancer clinical trials in Poland
Moleculin has undertaken and enrolled patients in two anti-cancer clinical trials in Poland.
M&As this week: Orion Biotechnology Canada, SOPHiA GENETICS, GI Partners
Orion Biotechnology Canada has completed the acquisition of K2Biomedical for an undisclosed sum.
Deals this week: Ultragenyx Pharmaceutical, Insmed, Harbour BioMed
US-based biopharmaceutical company Ultragenyx Pharmaceutical Inc has announced a public offering of shares of its common stock to raise $175m.